Skip to content

Kailas Jeevan Cream in Crackfoot

Evaluation of Kailas Jeevan (cream) in the Management of Padadari w. s. r to Cracked feet â?? An Open Clinical Trial - KJPD

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/034248
Enrollment
40
Registered
2021-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L949- Localized connective tissue disorder, unspecified

Interventions

Intervention1: Kailasa jeevan cream: having the combination of following herbs(Kailas Jeevan cream) described in traditional literature for the pittaja vyadhis and skin diseases like cracked feet, fis

Sponsors

Ayurveda Sumshodhanalaya Private Limited Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient presenting with signs and symptoms of Padadari Age group between 18-60 years, irrespective of sex, religion, occupation. Willing to give consent for participating in the study

Exclusion criteria

Exclusion criteria: Traumatic foot ulcer / Infected cracks Chronic ulcers due to Diabetes, Tuberculosis, Herpes, AIDS, Lichen planus, auto-immune disorder Any systemic illness which obstruct the duration of course of treatment. Any other conditions which in the opinion of investigator will place the subject at risk or will influence the conduct of study or interpretation of results

Design outcomes

Primary

MeasureTime frame
Reduction in the symptoms of PadadariTimepoint: 15days

Secondary

MeasureTime frame
Reduction in the complaints like pain, itching, burning sensation. Healing of cracks and Improved quality of life Timepoint: 30 days

Countries

India

Contacts

Public ContactDr Shrutika S Karoshi

KAHER Shri B M Kankanawadi Ayurveda Mahavidyalaya

shrutikakaroshi05@gmail.com8951432641

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026